Fox Run Management’s Maravai LifeSciences MRVI Stock Holding History

Fox Run Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$408K	Buy	+53,212	New	+$368K	0.05%	651
2024 Q4	–	Sell	-38,381	Closed	-$319K	–	1064
2024 Q3	$319K	Buy	+38,381	New	+$332K	0.07%	517
2024 Q2	–	Sell	-25,284	Closed	-$219K	–	959
2024 Q1	$219K	Buy	+25,284	New	+$171K	0.05%	611
2023 Q3	–	Sell	-17,958	Closed	-$223K	–	881
2023 Q2	$223K	Buy	+17,958	New	+$242K	0.06%	548
2022 Q2	–	Sell	-12,053	Closed	-$425K	–	668
2022 Q1	$425K	Buy	+12,053	New	+$404K	0.24%	145

Other funds holding MRVI

GTCR LLC Chicago, Illinois $4.29B AUM 4.12% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Fox Run Management's MRVI Position: Q3 2026 in Review

Fox Run Management opened a new position in Maravai LifeSciences (MRVI) in Q3 2026: 53,212 shares worth $408K. The stake represents 0.05% of the portfolio and ranks #651 among its holdings. This is a return to the name: Fox Run Management previously reported a position in MRVI as recently as Q3 2024.

Fox Run Management first reported a position in MRVI in Q1 2022 and has held it in 5 quarters since. The position peaked at $425K in Q1 2022. 146 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

Fox Run Management held 53,212 shares of Maravai LifeSciences worth $408K as of Q3 2026.
Maravai LifeSciences was a new Fox Run Management position in Q3 2026.
Maravai LifeSciences made up 0.05% of Fox Run Management's portfolio in Q3 2026, its #651 holding.
Fox Run Management first reported a position in Maravai LifeSciences in Q1 2022 and has held it in 5 quarters since.
Fox Run Management's Maravai LifeSciences position peaked at $425K in Q1 2022.
146 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.